The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| LIQUIDIA CORPORATION | COM NEW | 53635D202 | 21,877,963 | 1,860,371 | SH | SOLE | 1,860,371 | 0 | 0 | |||
| ROIVANT SCIENCES LTD | SHS | G76279101 | 147,638,400 | 12,480,000 | SH | SOLE | 12,480,000 | 0 | 0 | |||
| ASTRIA THERAPEUTICS INC | COM | 04635X102 | 939,210 | 105,057 | SH | SOLE | 105,057 | 0 | 0 | |||
| CULLINAN THERAPEUTICS INC | COM | 230031106 | 10,704,965 | 878,897 | SH | SOLE | 878,897 | 0 | 0 | |||
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 5,040,855 | 224,038 | SH | SOLE | 224,038 | 0 | 0 | |||
| EYEPOINT PHARMACEUTICALS | COM NEW | 30233G209 | 10,506,966 | 1,410,331 | SH | SOLE | 1,410,331 | 0 | 0 | |||
| INSMED INC | COM PAR $.01 | 457669307 | 21,206,810 | 307,167 | SH | SOLE | 307,167 | 0 | 0 | |||
| INTELLIA THERAPEUTICS, INC. | COM | 45826J105 | 2,518,338 | 215,981 | SH | SOLE | 215,981 | 0 | 0 | |||
| NURIX THERAPEUTICS, INC. | COM | 67080M103 | 8,408,217 | 446,296 | SH | SOLE | 446,296 | 0 | 0 | |||
| OCULAR THERAPEUTIX, INC. | COM | 67576A100 | 4,021,648 | 470,919 | SH | SOLE | 470,919 | 0 | 0 | |||
| PHARVARIS N V | COM | N69605108 | 3,979,750 | 207,603 | SH | SOLE | 207,603 | 0 | 0 | |||
| AGIOS PHARMACEUTICALS, INC. | COM | 00847X104 | 4,000,114 | 121,732 | SH | SOLE | 121,732 | 0 | 0 | |||
| ALLOGENE THERAPEUTICS, INC. | COM | 019770106 | 3,173,506 | 1,489,909 | SH | SOLE | 1,489,909 | 0 | 0 | |||
| ARVINAS, INC. | COM | 04335A105 | 1,660,640 | 86,627 | SH | SOLE | 86,627 | 0 | 0 | |||
| GERON CORPORATION | COM | 374163103 | 4,677,289 | 1,321,268 | SH | SOLE | 1,321,268 | 0 | 0 | |||
| DISC MEDICINE, INC. | COM | 254604101 | 3,575,760 | 56,400 | SH | SOLE | 56,400 | 0 | 0 | |||
| INTRA-CELLULAR THERAPIES INC. | COM | 46116X101 | 6,012,605 | 71,990 | SH | SOLE | 71,990 | 0 | 0 | |||
| MIRUM PHARMACEUTICALS, INC. | COM | 604749101 | 2,683,615 | 64,900 | SH | SOLE | 64,900 | 0 | 0 | |||
| SCHOLAR ROCK HOLDING CORPORATION | COM | 80706P103 | 1,383,040 | 32,000 | SH | SOLE | 32,000 | 0 | 0 | |||
| SPRINGWORKS THERAPEUTICS, INC. | COM | 85205L107 | 3,365,040 | 93,137 | SH | SOLE | 93,137 | 0 | 0 | |||